Abivax SA (ABVX)

Currency in EUR
60.60
-0.70(-1.14%)
Closed·
ABVX Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
ABVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
59.0061.00
52 wk Range
4.5164.40
Key Statistics
Prev. Close
60.6
Open
60.9
Day's Range
59-61
52 wk Range
4.51-64.4
Volume
54.34K
Average Volume (3m)
157.66K
1-Year Change
484.94%
Book Value / Share
-0.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABVX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
57.43
Downside
-5.23%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Abivax SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Abivax SA Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Compare ABVX to Peers and Sector

Metrics to compare
ABVX
Peers
Sector
Relationship
P/E Ratio
−24.6x−3.1x−0.5x
PEG Ratio
−2.260.050.00
Price/Book
−694.5x1.7x2.6x
Price / LTM Sales
432.4x4.5x3.3x
Upside (Analyst Target)
10.9%140.6%43.4%
Fair Value Upside
Unlock1.3%7.1%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 57.43
(-5.23% Downside)

Earnings

Latest Release
Jun 02, 2025
EPS / Forecast
-0.83 / -0.6561
Revenue / Forecast
994.00K / 3.41M
EPS Revisions
Last 90 days

ABVX Income Statement

People Also Watch

70.46
TEPRF
+3.62%
252.20
ESLX
+1.16%
80.84
SASY
+1.47%
31.75
RENA
+1.96%
27.58
DAST
+0.22%

FAQ

What Stock Exchange Does Abivax SA Trade On?

Abivax SA is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Abivax SA?

The stock symbol for Abivax SA is "ABVX."

What Is the Abivax SA Market Cap?

As of today, Abivax SA market cap is 4.58B.

What Is Abivax SA's Earnings Per Share (TTM)?

The Abivax SA EPS (TTM) is -2.94.

When Is the Next Abivax SA Earnings Date?

Abivax SA will release its next earnings report on 07 Sept 2025.

From a Technical Analysis Perspective, Is ABVX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Abivax SA Stock Split?

Abivax SA has split 0 times.

How Many Employees Does Abivax SA Have?

Abivax SA has 69 employees.

What is the current trading status of Abivax SA (ABVX)?

As of 08 Aug 2025, Abivax SA (ABVX) is trading at a price of 60.60, with a previous close of 60.60. The stock has fluctuated within a day range of 59.00 to 61.00, while its 52-week range spans from 4.51 to 64.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.